greeksoup/ stock research

Medtronic (MDT) Q1 FY2027 earnings: revenue $9.8 billion, up 13.7% on the year

Medtronic plc (MDT) reported revenue of $9.8 billion for Q1 FY2027, the quarter ended 31 July 2026, up 13.7% on the same quarter a year earlier. Net income was $1.5 billion, up 41.3% on the year, and diluted earnings per share $1.14. The figures are the company's own, from the 10-Q it filed with the SEC on 3 September 2026.

Revenue
$9.8 billion
+13.7% on the year · -0.5% on the quarter
Q2 FY2025Q1 FY2027
Operating margin
18.1%
16.8% a year earlier
Q2 FY2025Q1 FY2027
Net income
$1.5 billion
+41.3% on the year · +18.2% on the quarter
Q2 FY2025Q1 FY2027
Diluted EPS
$1.14
+40.7% on the year · +18.7% on the quarter
Q2 FY2025Q1 FY2027

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 1 raised, 1 narrowed, 1 kept.

  • Revenue rose 13.7% organically: Revenue was $9.756 billion, up 13.7% reported and 13.7% organic, about 200 basis points above the guidance midpoint.
  • Extra week added to growth: The 53-week fiscal year placed an extra week in the first fiscal month of Q1; the company estimates it added about $570 million to Q1 organic growth.
  • Non-GAAP EPS rose 15.1%: Non-GAAP diluted EPS was $1.45, up 15.1%; non-GAAP net income was $1.860 billion, up 14.4%. GAAP diluted EPS was $1.14, up 40.7%.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ1 FY2027Q4 FY2026Q1 FY2026On the quarterOn the yearLast 8 quarters
Revenue9,7569,8088,578-0.5%+13.7%
Cost of revenue3,4163,3983,001+0.5%+13.8%
Gross profit6,3406,4105,577-1.1%+13.7%
Gross margin65.0%65.4%65.0%
Research and development771671726+14.9%+6.2%
Selling, general and administrative3,1983,0572,806+4.6%+14.0%
Operating income1,7641,8721,445-5.8%+22.1%
Operating margin18.1%19.1%16.8%
Interest expense186177176+5.1%+5.7%
Pre-tax income1,7691,8331,302-3.5%+35.9%
Income tax289575255-49.7%+13.3%
Effective tax rate16.3%31.4%19.6%
Net income1,4701,2441,040+18.2%+41.3%
Net margin15.1%12.7%12.1%
Diluted EPS$1.14$0.96$0.81+18.7%+40.7%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ1 FY2027Q4 FY2026Q1 FY2026On the quarterOn the yearLast 8 quarters
Operating cash flow1,7932,5731,088-30.3%+64.8%
Capital expenditure503488504+3.1%-0.2%
Free cash flow1,2902,085584-38.1%+120.9%
Free cash flow margin13.2%21.3%6.8%
Cash from investing-1,619-917-719
Cash from financing-343-888-1,381
Depreciation and amortisation729716748+1.8%-2.5%
Share-based compensation12594.086.0+33.0%+45.3%
Buybacks267435123-38.6%+117.1%
Dividends paid921908910+1.4%+1.2%
Dividend per share$0.72n/a$0.71+1.4%
Diluted shares, weighted1,285m1,288m1,287m-0.2%-0.2%
Shares outstanding at period end1,280m1,280m1,282m-0.0%-0.1%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ1 FY2027Q4 FY2026Q1 FY2026On the quarterOn the yearLast 8 quarters
Shareholders' equity50,23249,46347,893+1.6%+4.9%
Non-controlling interest618609240+1.5%+157.5%
Debt28,15327,96128,609+0.7%-1.6%
Operating lease liabilitiesn/a989n/a
Finance lease liabilities52.054.051.0-3.7%+2.0%
Other liabilities14,25113,95214,179+2.1%+0.5%
Total liabilities and equity93,30693,02890,972+0.3%+2.6%
Fixed assets7,4737,4177,006+0.8%+6.7%
Goodwill43,18742,58742,007+1.4%+2.8%
Intangible assets10,23810,14611,223+0.9%-8.8%
Investments7,1287,2716,848-2.0%+4.1%
Cash and equivalents1,6911,9491,273-13.2%+32.8%
Receivables6,3576,6436,263-4.3%+1.5%
Inventory6,2155,9515,886+4.4%+5.6%
Other assets11,01711,06410,466-0.4%+5.3%
Total assets93,30693,02890,972+0.3%+2.6%

Questions

What was Medtronic's revenue in Q1 FY2027?

Medtronic (MDT) reported revenue of $9.8 billion for Q1 FY2027, the quarter ended 31 July 2026, up 13.7% on the same quarter a year earlier.

How much did Medtronic earn in Q1 FY2027?

Net income for Q1 FY2027 was $1.5 billion, up 41.3% on the year, and diluted earnings per share $1.14.

When did Medtronic report Q1 FY2027 results?

Medtronic filed its 10-Q for the quarter ended 31 July 2026 with the SEC on 3 September 2026.

Quarterly results, the last 20 quarters

Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026 *Q1 FY2027
Revenue7,8477,7638,0897,3717,5857,7278,5447,7027,9848,0898,5897,9158,4038,2928,9278,5788,9619,0179,8089,756
Cost of revenue2,4972,4592,5912,5162,5352,6892,9792,6282,7612,7823,0452,7612,9462,7793,1463,0013,0613,2613,3983,416
Gross profit5,3505,3045,4984,8555,0505,0385,5655,0745,2235,3075,5445,1545,4575,5135,7815,5775,9005,7566,4106,340
Gross margin68%68%68%66%67%65%65%66%65%66%65%65%65%66%65%65%66%64%65%65%
R&D676668652692676688640668698695674676697675684726754722671771
SG&A2,6152,5612,5692,5672,6172,6152,6162,6132,6862,6732,7642,6552,7572,7172,7202,8062,9652,9563,0573,198
Operating income1,5631,6591,6711,1251,4041,3921,5641,2681,3401,4831,0531,2781,5951,6461,4361,4451,6861,4641,8721,764
Operating margin20%21%21%15%19%18%18%16%17%18%12%16%19%20%16%17%19%16%19%18%
Interest expense136137143164118167187148180188203167209179174176181181177186
Pre-tax income1,4931,5891,6021,0441,3951,3751,5501,1961,3131,4728561,2681,5591,5401,2611,3021,5971,4041,8331,769
Tax rate12%7%7%11%69%11%23%33%31%9%23%17%18%15%16%20%13%18%31%16%
Net income1,3111,4801,4859294271,2221,1807919091,3226541,0421,2701,2941,0561,0401,3741,1431,2441,470
Net margin17%19%18%13%6%16%14%10%11%16%8%13%15%16%12%12%15%13%13%15%
Diluted EPS$0.97$1.10$1.10$0.70$0.32$0.92$0.88$0.59$0.68$0.99$0.49$0.80$0.99$1.01$0.82$0.81$1.07$0.89$0.96$1.14
Operating cash flow1,7692,2282,0571,0839221,5742,4608756612,4742,7779869582,5722,5281,0889252,7442,5731,793
Capital expenditure271330389426323332378354461346426520404476459504468444488503
Free cash flow1,4981,8981,6686575991,2422,0825212002,1282,3514665542,0962,0695844572,3002,0851,290
Buybacks4293941,40633614171.097.01522261321,6282,492288181274123372105435267
Dividends paid847847843903904904905918918917913898897897897910910911908921
Shares outstanding1,345m1,343m1,331m1,329m1,330m1,330m1,331m1,330m1,330m1,330m1,311m1,282m1,283m1,283m1,282m1,282m1,282m1,283m1,280m1,280m
Filing10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 31 July 2026, filed 3 September 2026: the filing.